Lobbying Expenditures in the US Health Care Sector, 2000-2020

JAMA Health Forum. 2022 Oct 7;3(10):e223801. doi: 10.1001/jamahealthforum.2022.3801.

Authors

William L Schpero¹, Thomas Wiener¹, Samuel Carter¹, Paula Chatterjee^{2

3}

Affiliations

¹ Division of Health Policy and Economics, Department of Population Health Sciences, Weill Cornell Medical College, New York, New York.
² Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
³ Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.

No abstract available

Plain language summary

This cross-sectional study uses publicly available, nonpartisan data to evaluate trends in lobbying expenditures across health care industries.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Drug Industry
Health Care Reform
Health Care Sector*
Health Expenditures
Lobbying*